CareNX Innovations Pvt. Ltd. is an IIT Bombay-incubated health technology company focused on improving access to affordable, AI-enabled maternal and women’s healthcare. Founded in 2015, CareNX develops point-of-care digital health solutions that enable early detection, remote monitoring, and clinical decision support, particularly in resource-constrained settings. Our flagship solutions include Fetosense, an AI-enabled wireless fetal monitoring platform for non-invasive NST/CTG monitoring, and SinDiColpo, a portable, battery-operated, AI-enabled cervical cancer screening solution designed for use at the point of care, including by primary healthcare providers. CareNX has deployed its solutions across hospitals and healthcare facilities in India and internationally, with 1 million+ pregnancies screened through its maternal health solutions. The company has been recognized by organizations including UNICEF, MIT Solve, Grand Challenges Canada, Fondation Botnar, Stanford Impact1, and the Government of India, and has received multiple innovation awards. With a multidisciplinary team spanning healthcare, biomedical engineering, AI, software, and business, CareNX works with leading clinicians and academic institutions to develop clinically relevant, scalable digital health solutions for underserved populations.